Losartan Potassium
Product Images NDC 71610-260

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71610-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 25 mg (71610 0260 30)

FDA Label Image

Figure 1 (92296151 E507 41b4 A040 C01b87ecb982 01)

FDA Label Image

Figure 2 (92296151 E507 41b4 A040 C01b87ecb982 02)

The text appears to be a graph or chart showing the percentage of patients who achieved the primary endpoint in a study involving Atenolol and Losartan Potassium Tablets. It also shows an adjusted risk reduction of 13% with a p-value of 0.021. The study was conducted for 60-65 months.*

FDA Label Image

Figure 3 (92296151 E507 41b4 A040 C01b87ecb982 03)

This appears to be a comparison of the effectiveness of Atenolol and Losartan Potassium Tablets on patients with fatal or non-fatal stroke. The graph provides data for the adjusted risk reduction of stroke, showing a 25% reduction in risk for the Losartan group compared to the Atenolol group with a p-value of 0.001. The study seems to have been conducted over a period of 68 months, with data points provided for each month within that timeframe.*

FDA Label Image

Figure 4 (92296151 E507 41b4 A040 C01b87ecb982 04)

FDA Label Image

Figure 5 (92296151 E507 41b4 A040 C01b87ecb982 05)

This appears to be a table or chart showing the percentage of patients experiencing an event in different populations. The table also includes a possible measure of risk reduction and a reference to Losartan Potassium Tablets and a Placebo. However, without further context or information, it is not possible to determine the precise purpose or meaning of this information.*

FDA Label Image

Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 06)

FDA Label Image

Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 07)

FDA Label Image

Aphena Pharma Solutions (TN)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.